Quantification of the b2-Adrenergic Feed Additives Ractopamine and Salbutamol by Reductive Amination–Assisted Modification
β2-Adrenergic compounds such as ractopamine and salbutamol can cause smooth muscle relaxation and are used for asthma and chronic obstructive pulmonary disease treatment. However, β2-adrenergic compounds may also cause some adverse cardiovascular effects or behavioral changes in humans; therefore- i...
Saved in:
Published in | Journal of food protection Vol. 82; no. 4; pp. 696 - 702 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Des Moines
Elsevier Limited
01.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | β2-Adrenergic compounds such as ractopamine and salbutamol can cause smooth muscle relaxation and are used for asthma and chronic obstructive pulmonary disease treatment. However, β2-adrenergic compounds may also cause some adverse cardiovascular effects or behavioral changes in humans; therefore- it is important for analytical chemists to determine the amounts of β2-adrenergic compounds in raw biological materials. Herein, novel analogs for standards and internal standard analogs were synthesized through reductive amination with isotopic H2-formaldehyde, D2-formaldehyde, and sodium cyanoborohydride. These analogs were used for quantifying β2-adrenergic compounds such as ractopamine and salbutamol in ground pork samples under multiple reaction monitoring scanning modes by tandem mass spectrometry. H2-Formaldehydemodified ractopamine and H2-formaldehyde-modified salbutamol acting as standards were used to prepare calibration curves, whereas D2-formaldehyde was used to generate D2-modified ractopamine and D2-modified salbutamol analogs acting as internal standards. The H2-modified ractopamine and H2-modified salbutamol showed excellent correlation coefficients, limits of detection, and limits of quantification. In mass spectrometric detection, H2-modified ractopamine showed 202% signal enhancement after modification and H2-modified salbutamol showed 17% signal enhancement after modification. |
---|---|
ISSN: | 0362-028X 1944-9097 |
DOI: | 10.4315/0362-028XJFP-18-499 |